Beller G A, Holzgrefe H H, Watson D D
Circulation. 1983 Dec;68(6):1328-38. doi: 10.1161/01.cir.68.6.1328.
Myocardial thallium-201 (201Tl) uptake and clearance after intravenous administration of dipyridamole (150 micrograms/kg) were determined in 12 open-chest anesthetized dogs with a partial coronary artery stenosis. 201Tl (1.5 mCi) was injected intravenously and myocardial biopsy specimens were obtained 10 min, 60 min, and 2 hr after injection. Serial changes in 201Tl activity in the normal zone and in the zone of partial stenosis were correlated with microsphere-determined regional blood flow and distal coronary pressure. Another nine dogs with equivalent stenosis not given dipyridamole before 201Tl served as controls. In the 12 dogs given dipyridamole, 201Tl activity at 10 min in the zone of stenosis was reduced to 42 +/- 5% of initial normal zone activity (p less than .001) and remained at 44 +/- 3% of initial normal zone activity at 2 hr. There was a good correlation (.81) between the percent reduction in myocardial 201Tl activity and the percent reduction of peak hyperemic flow as determined by measuring the percentage difference in peak coronary flow after a transient 10 sec occlusion under control and stenotic conditions. In contrast, 201Tl clearance was rapid in the normal zone, with 201Tl activity decreasing to 55 +/- 3% of initial normal zone activity by 2 hr. A redistribution pattern was produced because of the disparate clearance rates from hyperperfused and relatively hypoperfused myocardial regions. The relative 201Tl defect decreased from 58% to 11% from 10 min to 2 hr. In the normal zone dipyridamole increased epicardial flow from 1.03 +/- 0.09 (SEM) to 3.52 +/- 0.36 ml/min/g (p less than .0001) and endocardial flow from 1.19 +/- 0.09 to 2.96 +/- 0.20 ml/min/g (p = .0001). In the zone of partial stenosis the increase in epicardial flow after dipyridamole was less marked (1.01 +/- 0.10 to 1.55 +/- 0.15 ml/min/g; p = .009) and endocardial flow decreased (0.84 +/- 0.11 to 0.64 +/- 0.15 ml/min/g; p = .04). Coronary perfusion pressure distal to the stenotic zone fell from 65 +/- 3 to 50 +/- 3 mm Hg after dipyridamole. In the nine control dogs with equivalent stenosis, 201Tl uptake and washout were not significantly different in the stenotic zone compared with the normal zone. These data indicate that dipyridamole-induced vasodilation in the presence of a partial stenosis results in diminished uptake and delayed clearance compared with increased uptake and more rapid clearance in normally perfused myocardium producing an initial 201Tl defect with delayed redistribution.(ABSTRACT TRUNCATED AT 400 WORDS)
在12只开胸麻醉的部分冠状动脉狭窄犬中,静脉注射双嘧达莫(150微克/千克)后,测定心肌铊-201(201Tl)摄取和清除情况。静脉注射201Tl(1.5毫居里),并在注射后10分钟、60分钟和2小时获取心肌活检标本。正常区域和部分狭窄区域201Tl活性的系列变化与微球测定的局部血流和冠状动脉远端压力相关。另外9只具有同等狭窄且在注射201Tl前未给予双嘧达莫的犬作为对照。在给予双嘧达莫的12只犬中,狭窄区域10分钟时的201Tl活性降至初始正常区域活性的42±5%(p<0.001),并在2小时时保持在初始正常区域活性的44±3%。通过测量对照和狭窄条件下短暂10秒闭塞后冠状动脉峰值血流的百分比差异来确定,心肌201Tl活性降低百分比与充血峰值血流降低百分比之间存在良好相关性(r = 0.81)。相比之下,正常区域201Tl清除迅速,2小时时201Tl活性降至初始正常区域活性的55±3%。由于高灌注和相对低灌注心肌区域清除率不同,产生了再分布模式。相对201Tl缺损从10分钟时的58%降至2小时时的11%。在正常区域,双嘧达莫使心外膜血流从1.03±0.09(标准误)增加至3.52±0.36毫升/分钟/克(p<0.0001),使心内膜血流从1.19±0.09增加至2.96±0.20毫升/分钟/克(p = 0.0001)。在部分狭窄区域,双嘧达莫后心外膜血流增加不太明显(从1.01±0.10增加至1.55±0.15毫升/分钟/克;p = 0.009),心内膜血流减少(从0.84±0.11降至0.64±0.15毫升/分钟/克;p = 0.04)。狭窄区域远端的冠状动脉灌注压在双嘧达莫后从65±3降至50±3毫米汞柱。在9只具有同等狭窄的对照犬中,狭窄区域与正常区域相比,201Tl摄取和洗脱无显著差异。这些数据表明,在存在部分狭窄时,双嘧达莫诱导的血管扩张导致摄取减少和清除延迟,而正常灌注心肌中摄取增加和清除更快,产生初始201Tl缺损并伴有延迟再分布。(摘要截短于400字)